Other clinical trials of PARP inhibitors in prostate cancer were identified on the ClinicalTrials.gov website, searching for “prostate cancer” and “PARP” for studies published from database inception to July 1, 2019, without language restriction. The gene discussed is PARP1; the disease is Familial prostate cancer.